Drabant S - Search Results

1

Tofisopam inhibits the pharmacokinetics of CYP3A4 substrate midazolam.

Tóth M, Drabant S, Varga B, Végso G, Cseh A, Szentpéteri I, Klebovich I. Tóth M, et al. Among authors: drabant s. Eur J Clin Pharmacol. 2008 Jan;64(1):93-4. doi: 10.1007/s00228-007-0397-y. Epub 2007 Nov 8. Eur J Clin Pharmacol. 2008. PMID: 17989974 Clinical Trial. No abstract available.

2

Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam.

Drabant S, Tóth M, Bereczki A, Bajnógel J, Tömlö J, Klebovich I. Drabant S, et al. Eur J Clin Pharmacol. 2006 Jul;62(7):587-8. doi: 10.1007/s00228-006-0160-9. Epub 2006 Jun 22. Eur J Clin Pharmacol. 2006. PMID: 16791582 Clinical Trial. No abstract available.

3

Gas chromatography nitrogen phosphorous detection (GC-NPD) assay of tofisopam in human plasma for pharmacokinetic evaluation.

Tóth M, Bereczki A, Drabant S, Nemes KB, Varga B, Grézal G, Tömlo J, Lakner G, Klebovich I. Tóth M, et al. Among authors: drabant s. J Pharm Biomed Anal. 2006 Jun 16;41(4):1354-9. doi: 10.1016/j.jpba.2006.03.033. Epub 2006 May 8. J Pharm Biomed Anal. 2006. PMID: 16682162 Clinical Trial.

4

[Effect of tofisopam on CYP3A4 enzyme activity on human recombinant 3A4 supersome].

Tóth M, Bajnógel J, Egyed A, Drabant S, Tömlo J, Klebovich I. Tóth M, et al. Among authors: drabant s. Acta Pharm Hung. 2005;75(4):195-8. Acta Pharm Hung. 2005. PMID: 16711396 Hungarian.

5

Food interaction study of a new theophylline (Egifilin) 200 and 400 mg retard tablet in healthy volunteers.

Urmös I, Grézal G, Balogh Nemes K, Szállási T, Drabant S, Csörgo M, Klebovich I. Urmös I, et al. Among authors: drabant s. Int J Clin Pharmacol Ther. 1997 Feb;35(2):65-70. Int J Clin Pharmacol Ther. 1997. PMID: 9147710 Clinical Trial.

6

[The cognitive effect of alprazolam in healthy volunteers].

Drabant S, Tömlo J, Tóth M, Péterfai E, Klebovich I. Drabant S, et al. Acta Pharm Hung. 2006;76(1):25-31. Acta Pharm Hung. 2006. PMID: 17094673 Clinical Trial. Hungarian.

7

Different absorption profiles of deramciclane in man and in dog.

Kanerva H, Klebovich I, Drabant S, Urtti A, Nevalainen T. Kanerva H, et al. Among authors: drabant s. J Pharm Pharmacol. 1998 Oct;50(10):1087-93. doi: 10.1111/j.2042-7158.1998.tb03317.x. J Pharm Pharmacol. 1998. PMID: 9821653 Clinical Trial.

8

In vitro simulation of food effect on dissolution of deramciclane film-coated tablets and correlation with in vivo data in healthy volunteers.

Al-Behaisi S, Antal I, Morovján G, Szúnyog J, Drabant S, Marton S, Klebovich I. Al-Behaisi S, et al. Among authors: drabant s. Eur J Pharm Sci. 2002 Mar;15(2):157-62. doi: 10.1016/s0928-0987(01)00195-6. Eur J Pharm Sci. 2002. PMID: 11849912 Clinical Trial.

9

Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.

Balogh Nemes K, Horváth V, Grézal G, Horvai G, Hrabéczy-Páll A, Kocsi E, Drabant S, Csörgö M, Renczes G, Klebovich I. Balogh Nemes K, et al. Among authors: drabant s. Int J Clin Pharmacol Ther. 1998 May;36(5):263-9. Int J Clin Pharmacol Ther. 1998. PMID: 9629990 Clinical Trial.

10

Pharmacokinetics and safety of deramciclane during multiple oral dosing.

Kanerva H, Kilkku O, Helminen A, Rouru J, Scheinin M, Huupponen R, Klebovich I, Drabant S, Urtti A. Kanerva H, et al. Among authors: drabant s. Int J Clin Pharmacol Ther. 1999 Dec;37(12):589-97. Int J Clin Pharmacol Ther. 1999. PMID: 10599951 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page